fyarro
Generic: sirolimus protein-bound particles for injectable suspension (albumin-bound)·Code: ABI-009
fyarro: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | Phase 2 |
Get deeper analysis on fyarro
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis